Pharma & Health Business News

• 2019-11-11
• Drug groups and US states propose $48bn opioid deal
• Source: Financial Times - Permalink
2019-11-04
• Reckitt Benckiser: no kidding
• Source: Financial Times - Permalink
• Biogen shares soar on plan to seek Alzheimer’s drug approval
• Source: Financial Times - Permalink
• Alzheimer’s drug revival gives hope to millions
• Source: Financial Times - Permalink
• Eli Lilly raises earnings guidance as new drugs boost sales
• Source: Financial Times - Permalink
• Doctors label pensions solution a ‘sticking plaster’
• Source: Financial Times - Permalink
• AstraZeneca lifts sales outlook on boost from new drugs
• Source: Financial Times - Permalink
• Verseon faces painful reversal after Woodford biotech bubble bursts
• Source: Financial Times - Permalink
• Rising healthcare costs are another driver of US inequality
• Source: Financial Times - Permalink
• Merck results lifted by strong sales of cancer drug
• Source: Financial Times - Permalink
• Pfizer and Merck raise guidance on strong China growth
• Source: Financial Times - Permalink
• Amgen raises 2019 forecast despite competitive pressures
• Source: Financial Times - Permalink
• J&J says testing shows no asbestos in baby powder
• Source: Financial Times - Permalink
• Poorer countries see no silver bullet
• Source: Financial Times - Permalink
• Rich countries must pay more to achieve health for all
• Source: Financial Times - Permalink
• Bayer risks mount as US pesticide lawsuits double
• Source: Financial Times - Permalink
• GSK raises outlook again amid strong demand for shingles drug
• Source: Financial Times - Permalink
• Juul faces new claims it put public health at risk
• Source: Financial Times - Permalink
• Health data value’s challenge for policymakers
• Source: Financial Times - Permalink
• Harnessing the power of AI for global health
• Source: Financial Times - Permalink
• Future of AI and Digital Healthcare
• Source: Financial Times - Permalink
• Smith & Nephew raises revenue guidance for second straight quarter
• Source: Financial Times - Permalink
• Altria writes down Juul investment by $4.5bn
• Source: Financial Times - Permalink
• Childhood measles has ‘lasting effects’
• Source: Financial Times - Permalink
• US pension plans dodge queries on  healthcare holdings
• Source: Financial Times - Permalink
• Diabetes drug could halt progression of MS, study suggests
• Source: Financial Times - Permalink
2019-10-17
• ‘£16m typo’ delays Edinburgh hospital opening by a year
• Source: Financial Times - Permalink
• Ministers must level with public on NHS, say providers
• Source: Financial Times - Permalink
• J&J hit with $8bn court order over antipsychotic drug
• Source: Financial Times - Permalink
• Could micro-organisms revolutionise our food?
• Source: Financial Times - Permalink
• Chinese biotech: from copycat to innovator
• Source: Financial Times - Permalink
• Royal Philips/trade wars: bump in the night
• Source: Financial Times - Permalink
• A fifth of over-45s expect to leave work to become carers
• Source: Financial Times - Permalink
• Indian tycoons arrested over alleged wrongdoing
• Source: Financial Times - Permalink
• Nike shuts athletics training programme after doping scandal
• Source: Financial Times - Permalink
• More Four Seasons care homes at risk of closure
• Source: Financial Times - Permalink
• US Congress examines private equity role in surging healthcare costs
• Source: Financial Times - Permalink
• Life sciences hit by ‘lost decade’ as investment falls
• Source: Financial Times - Permalink
• Indivior shares rise as it boosts guidance for a second time
• Source: Financial Times - Permalink
• Danish biotech: white coat catalyst
• Source: Financial Times - Permalink
• J&J boosts outlook despite uncertainty over legal costs
• Source: Financial Times - Permalink
• Imperial sets up disease research centre with Saudi funds
• Source: Financial Times - Permalink
• From ‘catastrophic’ health spending to universal coverage
• Source: Financial Times - Permalink
• The ‘Elder’ pushing for universal health coverage
• Source: Financial Times - Permalink
• Kenya aims to deliver ‘health for all’ by 2022
• Source: Financial Times - Permalink
• ‘Modicare’ aims to stop ill health tipping Indians into poverty
• Source: Financial Times - Permalink
• Canopy wins UK’s first medical cannabis bulk import licence
• Source: Financial Times - Permalink
• There are solutions to the global drug price problem
• Source: Financial Times - Permalink
• Courier groups hired to keep medicine flowing after no-deal Brexit
• Source: Financial Times - Permalink
• Insulin maker Novo Nordisk walks moral tightrope
• Source: Financial Times - Permalink
2019-10-02